164 related articles for article (PubMed ID: 37962585)
1. Inhibition of sepsis-induced pancreatic injury by leukotriene receptor antagonism via modulation of oxidative injury, and downregulation of inflammatory markers in experimental rats.
Hagar HH; Alhazmi SM; Arafah M; Bayoumy NM
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3425-3435. PubMed ID: 37962585
[TBL] [Abstract][Full Text] [Related]
2. Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury.
Erşahin M; Çevik Ö; Akakın D; Şener A; Özbay L; Yegen BC; Şener G
Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):131-9. PubMed ID: 22986158
[TBL] [Abstract][Full Text] [Related]
3. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist.
Tuğtepe H; Sener G; Cetinel S; Velioğlu-Oğünç A; Yeğen BC
Eur J Pharmacol; 2007 Feb; 557(1):69-75. PubMed ID: 17173892
[TBL] [Abstract][Full Text] [Related]
4. Chronic renal failure-induced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast.
Sener G; Sakarcan A; Sehirli O; Ekşioğlu-Demiralp E; Sener E; Ercan F; Gedik N; Yeğen BC
Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):257-67. PubMed ID: 17499745
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of sepsis-induced hepatic and ileal injury in rats by the leukotriene receptor blocker montelukast.
Sener G; Sehirli O; Cetinel S; Ercan F; Yüksel M; Gedik N; Yeğen BC
Prostaglandins Leukot Essent Fatty Acids; 2005 Dec; 73(6):453-62. PubMed ID: 16162403
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory and Antioxidant Effects of Captopril Compared to Methylprednisolone in L-Arginine-Induced Acute Pancreatitis.
El-Ashmawy NE; Khedr NF; El-Bahrawy HA; Hamada OB
Dig Dis Sci; 2018 Jun; 63(6):1497-1505. PubMed ID: 29594979
[TBL] [Abstract][Full Text] [Related]
7. Montelukast protects against renal ischemia/reperfusion injury in rats.
Sener G; Sehirli O; Velioğlu-Oğünç A; Cetinel S; Gedik N; Caner M; Sakarcan A; Yeğen BC
Pharmacol Res; 2006 Jul; 54(1):65-71. PubMed ID: 16584888
[TBL] [Abstract][Full Text] [Related]
8. Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organs.
Sener G; Kabasakal L; Cetinel S; Contuk G; Gedik N; Yeğen BC
Burns; 2005 Aug; 31(5):587-96. PubMed ID: 15935562
[TBL] [Abstract][Full Text] [Related]
9. Vinpocetine ameliorates L-arginine induced acute pancreatitis via Sirt1/Nrf2/TNF pathway and inhibition of oxidative stress, inflammation, and apoptosis.
Abdelzaher WY; Ahmed SM; Welson NN; Marraiki N; Batiha GE; Kamel MY
Biomed Pharmacother; 2021 Jan; 133():110976. PubMed ID: 33202281
[TBL] [Abstract][Full Text] [Related]
10. Mesna Alleviates Cerulein-Induced Acute Pancreatitis by Inhibiting the Inflammatory Response and Oxidative Stress in Experimental Rats.
Hagar HH; Almubrik SA; Attia NM; Aljasser SN
Dig Dis Sci; 2020 Dec; 65(12):3583-3591. PubMed ID: 32088797
[TBL] [Abstract][Full Text] [Related]
11. Burn-induced oxidative injury of the gut is ameliorated by the leukotriene receptor blocker montelukast.
Kabasakal L; Sener G; Cetinel S; Contuk G; Gedik N; Yeğen BC
Prostaglandins Leukot Essent Fatty Acids; 2005 Jun; 72(6):431-40. PubMed ID: 15890506
[TBL] [Abstract][Full Text] [Related]
12. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
[TBL] [Abstract][Full Text] [Related]
13. Renoprotective effects of montelukast, a cysteinyl leukotriene receptor antagonist, against methotrexate-induced kidney damage in rats.
Abdel-Raheem IT; Khedr NF
Naunyn Schmiedebergs Arch Pharmacol; 2014 Apr; 387(4):341-53. PubMed ID: 24363042
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms underlying the protective effect of leukotriene receptor antagonist montelukast against doxorubicin induced testicular injury in rats.
Mohamed MZ; Zenhom NM
Prostaglandins Other Lipid Mediat; 2020 Aug; 149():106447. PubMed ID: 32173485
[TBL] [Abstract][Full Text] [Related]
15. Montelukast, a cysteinyl leukotriene receptor-1 antagonist protects against hippocampal injury induced by transient global cerebral ischemia and reperfusion in rats.
Saad MA; Abdelsalam RM; Kenawy SA; Attia AS
Neurochem Res; 2015 Jan; 40(1):139-50. PubMed ID: 25403620
[TBL] [Abstract][Full Text] [Related]
16. Endotoxemia in newborn rats attenuates acute pancreatitis at adult age.
Jaworek J; Konturek SJ; Macko M; Kot M; Szklarczyk J; Leja-Szpak A; Nawrot-Porabka K; Stachura J; Tomaszewska R; Siwicki A; Pawlik WW
J Physiol Pharmacol; 2007 Mar; 58(1):131-47. PubMed ID: 17440232
[TBL] [Abstract][Full Text] [Related]
17. The anti-inflammatory effect of montelukast, a cysteinyl leukotriene receptor-1 antagonist, against estradiol-induced nonbacterial inflammation in the rat prostate.
Said MM; Bosland MC
Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):197-205. PubMed ID: 27909742
[TBL] [Abstract][Full Text] [Related]
18. Cysteinyl leukotriene receptor antagonist montelukast ameliorates acute lung injury following haemorrhagic shock in rats.
Al-Amran FG; Hadi NR; Hashim AM
Eur J Cardiothorac Surg; 2013 Feb; 43(2):421-7. PubMed ID: 22851661
[TBL] [Abstract][Full Text] [Related]
19. Carvedilol attenuates l-arginine induced acute pancreatitis in rats through modulation of oxidative stress and inflammatory mediators.
El Morsy EM; Ahmed MAE
Chem Biol Interact; 2020 Aug; 327():109181. PubMed ID: 32569593
[TBL] [Abstract][Full Text] [Related]
20. Montelukast attenuates lipopolysaccharide-induced cardiac injury in rats.
Khodir AE; Ghoneim HA; Rahim MA; Suddek GM
Hum Exp Toxicol; 2016 Apr; 35(4):388-97. PubMed ID: 26089034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
